Antigenics (AGEN) Announces Positive Results With Herpes Treatment AG-707

Go back to Antigenics (AGEN) Announces Positive Results With Herpes Treatment AG-707
AGENUS (NASDAQ: AGEN) Delayed: 7.78 --0 (-0%)
Previous Close $7.78    52 Week High $7.49 
Open $7.78    52 Week Low $2.61 
Day High $7.78    P/E N/A 
Day Low $7.78    EPS $-1.10 
Volume 2,215